Home

Disease management

Read time: 4 min

Accentuate the negative: drawing attention to negative symptoms in schizophrenia

Impaired learning from experiences that bring reward and overestimating the effort needed to reach...

Read time: 3 min

Disclosure can create a virtuous circle as solidarity replaces stigma

Being open about mental illness is positive both for society and for the individual concerned,...

Read time: 3 min

Effective treatment of schizophrenia requires a patient-centered approach

Recognition of how people with schizophrenia interact and cope with their experiences is necessary...

Read time: 4 min

Early intervention in schizophrenia may improve long-term outcome

Schizophrenia may not be as disabling if identified and treated early, resulting in many benefits...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Essential elements for Alzheimer’s disease clinical trials

Stronger links between novel agents and their targets, more precise selection of patients, and...

Alzheimer's Disease

Read time: 4 min

Congress highlights

Dietary interventions that may lower the risk of Alzheimer’s disease

Increasing evidence shows that dietary interventions may lower the risk of developing Alzheimer...

Read time: 4 min

Improved cognition and insight into thinking: can we help these to be transferred to everyday life?

There’s ‘thinking’, and there’s ‘thinking about thinking’....

Read time: 4 min

Congress highlights

Pros and cons of persisting with antipsychotic treatment: assessing the evidence

Guidelines recommend that people with first-episode psychosis should where possible be maintained...

Read time: 5 min

Congress highlights

Recovery – from schizophrenia symptoms to well-being

Recovery in an important focus in the treatment and management of schizophrenia but what exactly is...

Read time: 4 min

Satellite symposium

Moving towards achieving full functional recovery in depression and getting back to pre-depression lifestyle

Addressing the cognitive symptoms of depression that affect attention, memory, executive function...

Read time: 4 min

Congress highlights

If one antipsychotic is good, why aren’t two better? Polypharmacy debated

Increased risk of side effects, reduced compliance, lack of rationale and, above all, no evidence...

Depression, Schizophrenia

Read time: 4 min

Congress highlights

E-mental health is revolutionizing and reshaping mental health practice worldwide

E-mental health is revolutionizing and reshaping mental health care practice worldwide. This...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country